Literature DB >> 8236510

A calcitonin-producing neuroendocrine tumor of the larynx: a case report.

L Insabato1, G De Rosa, L M Terracciano, G Lupoli, D Montedoro, C Ravetto.   

Abstract

A moderately differentiated neuroendocrine carcinoma of the larynx is described. Although the patient had normal serum calcitonin level 36 months before, its level was elevated at the time the neck node was removed. This study supports the hypothesis that a diagnosis of calcitonin-producing neuro-endocrine tumor of the larynx with increased plasma calcitonin is possible and should be considered to avoid unnecessary thyroidectomy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8236510     DOI: 10.1177/030089169307900315

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  5 in total

Review 1.  [Definition of R1 resection in thyroid carcinoma].

Authors:  S Synoracki; Ch Wittekind; H Dralle; K W Schmid
Journal:  Chirurg       Date:  2017-09       Impact factor: 0.955

Review 2.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms.

Authors:  Ozgur Mete; Bruce M Wenig
Journal:  Head Neck Pathol       Date:  2022-03-21

Review 3.  [Thyroid C cells and their pathology: Part 2: Medullary thyroid carcinoma].

Authors:  S Synoracki; S T Schmid; S Ting; K W Schmid
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

4.  Calcitonin-Secreting Neuroendocrine Carcinoma of Larynx with Metastasis to Thyroid.

Authors:  Lauren LaBryer; Ravindranauth Sawh; Colby McLaurin; R Hal Scofield
Journal:  Case Rep Endocrinol       Date:  2015-09-28

Review 5.  Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature.

Authors:  Tiziana Feola; Giulia Puliani; Franz Sesti; Roberta Modica; Marco Biffoni; Cira Di Gioia; Raffaella Carletti; Emanuela Anastasi; Valentina Di Vito; Roberta Centello; Andrea Lenzi; Andrea M Isidori; Antongiulio Faggiano; Elisa Giannetta
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-16       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.